Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of BIBR 1048 in Hip Replacement
NCT02170935Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2002
- Primary completion
- Jun 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of dabigatran etexilate oral solution in venous thromboembolism (VTE), sponsored by Boehringer Ingelheim. Started Apr 2002; status: completed.
02
Drugs
dabigatran etexilate oral solution
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02170935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170935.